In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor.

XM323 represents a novel class of potent inhibitors of human immunodeficiency virus (HIV) protease. In vitro studies have shown that inhibition of this enzyme translates into potent inhibition of replication of HIV type 1 (HIV-1) and HIV-2. The inhibition of virus replication was assessed with three...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Otto, M J, Reid, C D, Garber, S, Lam, P Y, Scarnati, H, Bacheler, L T, Rayner, M M, Winslow, D L
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1993
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8109924/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.12.2606
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!